Unknown

Dataset Information

Interpreting treatment effects from clinical trials in the context of real-world risk information: end-stage renal disease prevention in older adults.


ABSTRACT:

Importance

Older adults are often excluded from clinical trials. The benefit of preventive interventions tested in younger trial populations may be reduced when applied to older adults in the clinical setting if they are less likely to survive long enough to experience those outcomes targeted by the intervention.

Objective

To extrapolate a treatment effect similar to those reported in major randomized clinical trials of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for prevention of end-stage renal disease (ESRD) to a real-world population of older patients with chronic kidney disease.

Design, setting, and participants

Simulation study in a retrospective cohort conducted in Department of Veterans Affairs medical centers. We included 371

SUBMITTER: O'Hare AM 

PROVIDER: S-EPMC4119007 | biostudies-literature | 2014 Mar

REPOSITORIES: biostudies-literature